Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -9498.2% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 130.1 | n/a |
Pr/Book | 3.5 |
Latest | F'cast | |
---|---|---|
Revenue | 12.2% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-19 | 2.36 | (4.52) | (13.87)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-20 | 1.06 | (20.38) | (54.48)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-21 | 0.69 | (1.85) | (1.19)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-22 | 0.05 | (5.63) | 5.50p | 3.2 | n/a | n/a | n/a | 0.0% |
30-Jun-23 | 0.06 | (5.98) | (5.50)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Clinical Trial Agreement | 24-Apr-2024 | 15:36 | RNS |
Application for Listing & Total Voting Rights | 03-Apr-2024 | 17:00 | RNS |
NICE recommends the Genedrive CYP2C19-ID Kit | 03-Apr-2024 | 07:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 4.92p |
Change Today | -0.083p |
% Change | -1.67 % |
52 Week High | 22.25 |
52 Week Low | 3.13 |
Volume | 1,195,694 |
Shares Issued | 143.14m |
Market Cap | £7.04m |
RiskGrade | 747 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
10:20 | 17,378 @ 5.15p |
10:17 | 10,116 @ 5.15p |
10:06 | 9,100 @ 4.91p |
09:58 | 3,827 @ 5.23p |
09:40 | 49,884 @ 4.99p |
You are here: research